111 related articles for article (PubMed ID: 6127352)
1. Tardive dyskinesia in India: a prevalence study.
Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Vahora SA; Thatte S; Vevaina T; Bharadwaj J
J Clin Psychopharmacol; 1982 Oct; 2(5):341-4. PubMed ID: 6127352
[TBL] [Abstract][Full Text] [Related]
2. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
Go CL; Rosales RL; Caraos RJ; Fernandez HH
Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
[TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia and diabetes mellitus.
Ganzini L; Casey DE; Hoffman WF; Heintz RT
Psychopharmacol Bull; 1992; 28(3):281-6. PubMed ID: 1362276
[TBL] [Abstract][Full Text] [Related]
4. Clinical and familial correlates of tardive dyskinesia in India and Israel.
Bhatia T; Sabeeha MR; Shriharsh V; Garg K; Segman RH; Uriel HL; Strous R; Nimgaonkar VL; Bernard L; Deshpande SN
J Postgrad Med; 2004; 50(3):167-72; discussion 172. PubMed ID: 15377799
[TBL] [Abstract][Full Text] [Related]
5. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
Bailey LG; Maxwell S; Brandabur MM
Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
[TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
Ezrin-Waters C; Seeman MV; Seeman P
J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
8. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
[TBL] [Abstract][Full Text] [Related]
10. A summary of current knowledge of tardive dyskinesia.
Baldessarini RJ
Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of tardive dyskinesia.
Woerner MG; Kane JM; Lieberman JA; Alvir J; Bergmann KJ; Borenstein M; Schooler NR; Mukherjee S; Rotrosen J; Rubinstein M
J Clin Psychopharmacol; 1991 Feb; 11(1):34-42. PubMed ID: 1674949
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
13. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
14. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
Raja M; Azzoni A
Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
[TBL] [Abstract][Full Text] [Related]
16. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.
Chouinard G; Annable L; Ross-Chouinard A; Mercier P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):21S-26S. PubMed ID: 3220967
[TBL] [Abstract][Full Text] [Related]
17. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
Gałecki P; Pietras T; Szemraj J
Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
[TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic-induced tardive dyskinesias in France].
Bourgeois M
Encephale; 1988 Sep; 14 Spec No():195-201. PubMed ID: 2905646
[TBL] [Abstract][Full Text] [Related]
20. [Tardive dyskinesia: a review].
Crespo Facorro B; Payá González B; Ruiz Fernández V; Carbonell Masia C
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):118-27. PubMed ID: 9245189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
